The Johnson & Johnson Coronavirus Shot is Kaput
Last week, the United States Food and Drug Administration (FDA) revoked the Emergency Use Authorization for Johnson & Johnson coronavirus shots. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, noted in a Thursday letter that the FDA made the revocation at the request of Janssen Biotech, a Johnson & Johnson subsidiary, that had related that the company would not be updating its shots, the latest “lots” purchased by the US government have expired, and “there is no demand for new lots.”The lack of demand is little surprise.
